Home / Agencies / DOJ / 2024-27018
Final Rule

Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

Agency
DOJ
Document Number
2024-27018
Published
November 19, 2024
Effective Date
January 1, 2025

Abstract

The Drug Enforcement Administration (DEA) in concert with the Department of Health and Human Services (HHS) is issuing a third extension of telemedicine flexibilities for the prescribing of controlled medications, through December 31, 2025.

Federal Register Source

This document is published by the Office of the Federal Register, National Archives and Records Administration. Access the full regulatory text, preamble, and docket comments below.

View Full Text on FederalRegister.gov →

Opens in new tab · federalregister.gov

Frequently Asked Questions

What is the 2024-27018 Federal Register document?
Document 2024-27018 is a Final Rule published by the Department of Justice in the Federal Register on November 19, 2024, with an effective date of January 1, 2025. The Drug Enforcement Administration (DEA) in concert with the Department of Health and Human Services (HHS) is issuing a third extension of telemedicine flexibilities for the prescribing of controlled medications, through December 31, 2025. View the original at https://www.federalregister.gov/documents/2024/11/19/2024-27018/third-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled.
Is document 2024-27018 an economically significant rule?
No. Document 2024-27018 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.

Other Rules from DOJ

Counter-UAS Authority for State, Local, Tribal, and Territorial Law Enforcement and Correctional Agencies
Final Rule · Jul 2026
Licensee “eZ Check” Verification for Transfers; Withdrawing Direct Final Rule
Final Rule · Jul 2026
Fingerprint and Photograph Requirements for Firearms Applications
Proposed · Jul 2026
Registering NFA Firearms That Fall Out of Government Contract
Proposed · Jul 2026
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
Proposed · Jul 2026
Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
Proposed · Jul 2026
View all Department of Justice rules →

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official state legislatures, IAPP, NCSL, and federal regulatory trackers. See our methodology for details. Retrieved and formatted by PlainRegWatch Editorial

Every figure on PlainRegWatch is rendered directly from state source data, no number is typed in by an editor. This page draws directly on federal and state source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.